NCT01776541 - Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults | Biotech Hunter

Enrollment

979

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

May 31, 2014

Conditions

Pandemic H5N1 Influenza

Interventions

BIOLOGICAL

Adjuvanted H5N1 pandemic influenza vaccine

Comparison of two doses of aH5N1c vaccine

Trial Locations (8)

80 Faculty of Tropical Medicine, Bangkok

48 Hunter Clinical Research, Newcastle

46 CMAX, Adelaide

47 Linear Clinical Research, Nedlands

1 Miami Research Associates, Miami

2 Mercy Health Research, St Louis

3 Saint Louis University, St Louis

4 Benchmark Medical Research, Austin